126 results
8-K
EX-4.2
VBIV
VBI Vaccines Inc.
11 Apr 24
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:07pm
appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company … as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably
8-K
EX-4.1
VBIV
VBI Vaccines Inc.
11 Apr 24
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:07pm
by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall … selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
8-K
EX-10.1
z9kt8k6m74zh 5d1h
11 Apr 24
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:07pm
424B5
mz6h w3kl9ya
11 Apr 24
Prospectus supplement for primary offering
9:06am
424B5
3wjo47k
7 Jul 23
Prospectus supplement for primary offering
5:25pm
424B5
pxn9svvqg79 hmn
7 Jul 23
Prospectus supplement for primary offering
5:20pm
8-K
EX-4.1
ogl0o014ozol titra
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm
8-K
EX-1.1
hu2v0lix4a 24
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm
424B5
6mqunan4q2
5 Jul 23
Prospectus supplement for primary offering
4:31pm
8-K
EX-10.1
oody10zfkvdmezfbudo
5 Jul 23
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-10.1
a0ojklfpv
15 Sep 22
VBI Vaccines Secures $100 Million Debt Facility From K2 HealthVentures
5:01pm